Microgravity, your future health will be cultivated in space
Low Earth orbit (LEO) offers unique microgravity opportunities for research and technology advancement, as well as for developing new drugs through future space projects.
Is a director at the digital research & intelligence wing of Novo Nordisk A/S in Denmark. He has PhD in computer science from Univ. of Copenhagen with 14+ years of experience in data science, statistics, modelling, machine learning, visualisation, and QC within early research, preclinical, and clinical pharmaceutical settings. He co-authored 35+ research articles published in high-impact scientific journals. Before Novo Nordisk, he worked with various industries such as Philips, GE research, Siemens Corporate Research, University of Pennsylvania, Spanish National Center for Cardiovascular Research and Novo Nordisk Foundation Centers for Protein Research & Stem Cell Biology
